Our Executive Committee
Vasant (Vas) Narasimhan, M.D.
Chief Executive Officer
Chief People & Organization Officer
Chief Digital Officer
James (Jay) Bradner, M.D.
President of the Novartis Institutes for BioMedical Research (NIBR)
Chief Financial Officer
Shannon Thyme Klinger
Chief Legal Officer
Steffen Lang, Ph.D.
Global Head of Novartis Technical Operations (NTO)
Klaus Moosmayer, Ph.D.
Chief Ethics, Risk & Compliance Officer
Chief Executive Officer of Sandoz
Susanne Schaffert, Ph.D.
President of Novartis Oncology
John Tsai, M.D.
Head of Global Drug Development and Chief Medical Officer
President of Novartis Pharmaceuticals
Head of Novartis Business Services (NBS)
1 Effective February 1, 2021, the Digital function will be merged with NBS to form a new Customer & Technology Solutions (CTS) unit, which Mr. Weltevreden has been appointed to lead. Mr. Bodson will step down from the Executive Committee on February 1, 2021.